© The Rockefeller University Press, 0022-1007/1997/11/1603/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 9, November 3, 1997 1603-1608
Prostaglandin E2 and Tumor Necrosis Factor 
Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production
Claudia Rieser*,
Günther Böck
,
Helmut Klocker*,
Georg Bartsch*, and
Martin Thurnher*
From the * Department of Urology, and the Institute for General and Experimental Pathology, University of Innsbruck, A-6020 Innsbruck, Austria
 |
Abstract
|
|---|
Interleukin (IL)-12 is a proinflammatory cytokine that contributes to innate resistance and to the development of antigen-specific T cell responses. Among other effects, prostaglandin E2 (PGE2) inhibits the production of IL-12 by macrophages activated with lipopolysaccharide (LPS). Here we investigated the effects of PGE2 on human dendritic cells (DCs) which develop in the presence of GM-CSF and IL-4. We demonstrate that in the absence of LPS, PGE2 dose dependently stimulated the production of IL-12 by DCs. Although PGE2 alone stimulated the production of low amounts of IL-12 only, it synergized with tumor necrosis factor (TNF)-
to induce high levels of IL-12 production by DCs. Addition of TNF- in the absence of PGE2 had no effect on IL-12 production. Conversely, in the presence of LPS, PGE2 inhibited IL-12 production by DCs in a dose-dependent manner. The combination of PGE2 and TNF- efficiently silenced mannose receptor–mediated endocytosis in DCs and readily induced neo-expression of the CD83 antigen. In addition, the expression of various surface antigens such as major histocompatibility complex class I and II, adhesion, as well as costimulatory molecules was upregulated by this treatment. The effects of PGE2 on IL-12 synthesis and CD83 expression could be mimicked by dibutyryl-cAMP and forskolin, indicating that they were due to the intracellular elevation of cAMP levels. DC treated with PGE2 and TNF- were most potent in stimulating allogeneic T cell proliferation. Our data demonstrate that PGE2 contributes to the maturation of human DCs and that PGE2 can be a potent enhancer of IL-12 production by human DCs.
Address correspondence to Dr. Martin Thurnher, The Department of Urology, Anichstrasse 35, 6020 Innsbruck, Austria. FAX: 43-512-504-4817; E-mail: martin.thurnher{at}uibk.ac.at
Tissue injury induces an acute inflammatory response mediated by components of innate resistance such as macrophages which release proinflammatory factors (1). The local inflammatory response at the site of injury is characterized by the development of erythema, edema, and hyperalgesia (2). In addition to several vasoactive factors such as histamine, bradykinin, and nitric oxide (3, 4), prostaglandins (PGs) contribute to this process. The therapeutic benefit of nonsteroidal antiinflammatory drugs such as aspirin or indomethacin in inflammatory diseases is based on the inhibitory effects of these drugs on the synthesis of PGs (5). The importance of PGs in the inflammatory process has also been demonstrated in a rat model of carrageenan-induced paw inflammation (2). In this model, the selective neutralization of PGE2 by an antibody prevented the carrageenan-induced development of tissue edema and hyperalgesia. However, injection of PG into the skin causes minimal swelling demonstrating that PGs on their own have little inflammatory capacity. In contrast, in the presence of other mediators, PGs can synergistically amplify the local inflammatory response (6, 7). In contrast to these proinflammatory activities, PGs are also known to inhibit the production of proinflammatory cytokines by macrophages activated with LPS. PGE2 has been shown to inhibit the LPS-induced human IL-12 production in whole blood cultures (8) and the LPS-stimulated murine TNF- production in cultured macrophages (9), supporting the view that PGE2 acts as a suppressor of APC.
APCs link the inflammatory response to an Ag-specific immunological response (1). Dendritic cells (DCs) are the most potent APCs (10). DCs are highly responsive to inflammatory stimuli such as bacterial LPS and TNF- which induce a series of phenotypic and functional changes in DCs. These changes, which have been collectively referred to as DC maturation (11), include the silencing of Ag uptake by endocytosis (12), the upregulation of surface molecules related to T cell activation (12), and the active production of a number of cytokines including TNF- and IL-12 (13, 14). Upon local accumulation of TNF-, DCs migrate to the T cell areas of secondary lymphoid organs to activate Ag-specific T cells (15).
In the present work, we have investigated the effects of PGE2 on cultured human DCs. We show that PGE2 in the absence of LPS stimulation is capable of inducing the production of IL-12 by DCs. Although PGE2 on its own was a weak stimulus of IL-12 production, PGE2 in concert with TNF- induced the production of high levels of IL-12 in DC cultures. Moreover, the combination of PGE2 and TNF- turned out to be a potent stimulus of DC maturation.
|
Materials and Methods
|
|---|
Media and Reagents.
The medium used in this study was RPMI 1640 supplemented with 1% heat-inactivated (30 min, 56°C) pooled human AB serum, 50 U/ml penicillin, 50 µg/ml streptomycin, 2 mM L-glutamine, 10 mM Hepes, 0.1 mM nonessential amino acids, 1 mM pyruvate, and 5 x 10–5 M 2-mercaptoethanol (all from Boehringer Ingelheim Bioproducts, Vienna, Austria). Human albumin (for intravenous use; Octapharma, Vienna, Austria) was added to a final concentration of 2 mg/ml (= complete medium). Recombinant human GM-CSF (Leucomax; 1.11 x 107 U/mg) was from Novartis (Basel, Switzerland). Recombinant human IL-4 (2 x 107 U/mg) was supplied by the Schering-Plough Research Institute (Kenilworth, NJ). Recombinant human TNF- (107 U/mg) was purchased from Genzyme (Cambridge, MA). PGE2 was purchased from Sigma Chemical Company (St. Louis, MO) and from Calbiochem-Novabiochem International (San Diego, CA). Forskolin, N-2-O-dibutyryl-cAMP (db-cAMP), LPS (from Salmonella abortus equi), and fluoresceinated Dextran (FITC-DX) were all from Sigma Chemical Co.
Culture of Human DCs.
DCs were generated from PBMCs as described (16, 17). In brief, PBMCs were isolated from leukocyte-enriched buffy coats by standard density gradient centrifugation on Ficoll-Paque (Pharmacia, Uppsala, Sweden), resuspended in complete medium and 5.0 x 107 PBMCs were allowed to adhere in 75-cm2 cell culture flasks (45 min 37°C). Nonadherent cells were removed and adherent cells were cultured in 10 ml of complete medium containing 1,000 U/ml of each GM-CSF and IL-4. DCs were developed under essentially endotoxin-free conditions as indicated by the absence of spontaneous TNF- production (<5 pg/ml of TNF-/5 x 105 DC). On day 2, 5 ml of fresh medium containing 1,000 U/ml of GM-CSF and IL-4 were added. After 5 d of culture, cells were harvested, washed extensively, and recultured in cytokine-containing medium at 3 x 105 cells/ml with or without inflammatory mediators. After 48 h, supernatants were harvested for IL-12 ELISA assays and the cells were analyzed for surface Ag expression by flow cytometry.
Flow Cytometric Measurement of Surface Ag Expression and Endocytic Activity.
To determine surface Ag expression, cells (105 DC in 50 µl) were labeled with primary mAb in complete medium followed by FITC-conjugated F(ab')2 fragments of goat anti–mouse Ig (Dako, Glostrup, Denmark). The following mAbs were used: VIM-13 (IgM, anti-CD14, a gift of Dr. W. Knapp, Vienna, Austria), G46-2.6 (IgG1, anti-HLA-ABC), L243 (IgG2a, anti-HLA-DR), HB-15a (IgG2b, anti-CD83), 84H10 (IgG1, anti-CD54), AIDC58 (IgG2a, anti-CD58), BB1 (IgM, anti-CD80), BU63 (IgG1, anti-CD86), 5C3 (IgG1, anti-CD40), 1G10 (IgG1, anti-CD43), G44-26 (IgG2b, anti-CD44). Washes were in HBSS containing 0.2% albumin. After the last wash, the cells were stored in HBSS containing 0.2% albumin and 2% formaldehyde.
The endocytic activity of DCs was measured as described previously (12). FITC-DX was used to measure mannose receptor– mediated endocytosis. Cells (105) were incubated with FITC-DX (0.5 mg/ml) for 30 min at 37°C (control at 0°C) and then washed extensively. The samples were analyzed on a FACScan® (Becton Dickinson, Mountain View, CA). Data were analyzed and presented using CellQuest® software from Becton Dickinson.
Quantitation of IL-12.
Day-5 DCs (3 x 105 cells/ml) were incubated for 48 h with various stimuli and IL-12 was measured in culture supernatants by ELISA using a commercially available kit (Genzyme) that detects both IL-12 p40 and the bioactive IL-12 p70 heterodimer consisting of p40 and p35. IL-12 was quantitated using a microtiter plate reader.
T Cell Proliferation Assay.
DCs were either untreated or treated with TNF-, PGE2, or PGE2 plus TNF- for 48 h. Irradiated (3,000 rad) DCs (1 x 103 or 5 x 104) were then cultured with a constant number of 2 x 105 allogeneic T cells in 96-well flat-bottomed tissue culture plates in medium containing 5% pooled human serum. T cell proliferation was measured as [3H]thymidine incorporation (1 µCi/well; 6.7 Ci/mmol, New England Nuclear, Boston, MA). Cells were pulsed during the last 16 h of a 5-d culture period, harvested onto glass fiber filters using a Skatron cell harvester (Skatron Instruments, Lier, Norway), and analyzed in a liquid scintillation counter. Results are expressed as the mean cpm of triplicate wells ± SD.
|
Results
|
|---|
PGE2 Stimulates IL-12 Production in Human DCs.
Day-5 DCs were exposed to graded doses of PGE2, and IL-12 was determined in culture supernatants after 48 h. Fig. 1 A demonstrates that PGE2 stimulated IL-12 production in a dose-dependent fashion. However, the total amount of IL-12 induced by PGE2 was relatively low. PGE2-dependent IL-12 production by DCs occurred in the absence of endogenous TNF- production (data not shown). TNF- has been described to enhance IL-12 production in the context of LPS stimulation (18). Therefore, we tested the effects of combinations of PGE2 and TNF- on IL-12 production by DCs. In the presence of TNF-, PGE2 dose dependently stimulated high level IL-12 production in DCs (Fig. 1 C). Conversely, the level of IL-12 production also depended on the dose of TNF- (Fig. 1 D). The effects of PGE2 and TNF- were synergistic since TNF- alone completely failed to induce IL-12 production by DCs (Fig. 1 C). In contrast, PGE2 inhibited the LPS-induced IL-12 production by DCs (Fig. 1 B) confirming previous observations (8). PGE2 from two different commercial sources were used with consistent results.
PGE2 and TNF- Cooperate to Activate Human DCs.
IL-12 production by DCs is always associated with DC activation which can be induced by treatment with LPS (14), BCG (13), a monocyte-conditioned medium (19, 20), or by cross-linking of the CD40 Ag (21). DC activation, which has also been referred to as DC maturation, is characterized by the neo-expression of the CD83 Ag (22), by the upregulation of molecules related to Ag presentation (12, 22), and by the downmodulation of endocytic activity (12, 23). Therefore, we then tested the effects of PGE2 and TNF- on the process of DC maturation.
The combination of PGE2 and TNF- turned out to be potent in inducing CD83 expression in DCs (Fig. 2 A). Addition of PGE2 (1 µM) along with TNF- (1,000 U/ml) induced CD83 expression in 75% of the cells within 24 h (data not shown) and in almost all cells within 48 h (Fig. 2 A). Addition of either substance alone also induced CD83 expression, although to a smaller extent (Fig. 2 A). Moreover, treatment with PGE2 plus TNF- efficiently upregulated the expression of MHC class I and II molecules, adhesion molecules (CD54, CD58), and costimulatory molecules (CD80, CD86) in DCs (Fig. 3). The expression of CD40 and CD44 was also enhanced. Inspection of these cells by phase contrast microscopy revealed a pronounced dendritic morphology with numerous large veils, a feature of mature DCs (data not shown; reference 10). Conversely, the ability to capture soluble Ag (DX) by mannose receptor–mediated endocytosis was almost completely downregulated in DCs cultured in the presence of PGE2 and TNF- (Fig. 2 B). Again, either substance alone also downmodulated Ag uptake, although less efficiently.
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Regulatory effects of PGE2 on CD83 expression and Ag uptake. (A) Day-5 DCs were incubated with PGE2 (1 µM), TNF- (1,000 U/ml), LPS (10 ng/ml), or PGE2 plus TNF-. After 48 h, cells were harvested and CD83 expression was measured by flow cytometry. The isotype control (IgG2b) is also presented (dotted lines). (B) Day-5 DCs were incubated with PGE2 (1 µM), TNF- (1,000 U/ml), or PGE2 plus TNF-. After 24 h, cells were harvested and incubated with FITC-DX for 30 min at 37°C (controls at 0°C, dotted lines), washed, and analyzed by flow cytometry.
| |
PGE2 Effects on DCs Are Mimicked by Nonphysiologic Modulators of cAMP.
Most of the effects of PGE2 are mediated by the intracellular second messenger cAMP (24). Therefore, PGE2 effects can be mimicked by nonphysiologic modulators of cAMP such as forskolin and db-cAMP. To investigate the mechanism of the stimulatory effects of PGE2 on DCs, we tested the effects of forskolin or db-cAMP either alone or in the presence of TNF- on IL-12 synthesis and CD83 expression in human DCs. Fig. 4 A demonstrates that db-cAMP (100 µM) stimulated low level IL-12 production and synergized with TNF- to induce substantial IL-12 production by DCs. CD83 expression was also induced by db-cAMP (Fig. 4 B). Forskolin at 10 µM failed to induce IL-12 production (Fig. 4 A). Higher concentrations of forskolin could not be tested due to the high toxicity of this compound. However, in the presence of TNF- forskolin at 10 µM induced measurable IL-12 production (Fig. 4 A). Forskolin also induced CD83 expression (Fig. 4 B).
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 4 Mimicry of PGE2 effects on IL-12 synthesis and CD83 expression by nonphysiologic modulators of cAMP. Day-5 DCs were incubated with db-cAMP (100 µM) or forskolin (10 µM) either alone or in combination with TNF- (1,000 U/ml). After 48 h, supernatants were analyzed for the presence of IL-12 using a specific ELISA (A) and the cells were analyzed for CD83 expression by flow cytometry (B). Data are given as mean ± SEM of four independent experiments.
| |
PGE2 Enhances the Accessory Cell Capacity of Human DCs.
High levels of adhesion molecules expressed by mature DCs (Fig. 3) contribute to the T cell stimulatory potential of DCs by facilitating the formation of clusters with T cells (11). DCs treated with PGE2 and TNF- were most potent in cluster formation with allogeneic T cells (data not shown). Either substance alone also enhanced cluster formation, although at a lower level.
The formation of clusters serves to establish close contacts between DCs and T cells, thereby favoring TCR engagement and T cell activation (11). Fig. 5 shows that DCs treated with PGE2 and TNF- also exhibited the highest capacity to stimulate allogeneic T cell proliferation. Treatment of DCs with either substance alone also enhanced T cell proliferation, but to a smaller extent (Fig. 5).
|
Discussion
|
|---|
PGE2 has been demonstrated to be a potent inhibitor of the LPS-induced human IL-12 production (8). In the present work, we demonstrate that PGE2 in the absence of LPS is capable of stimulating IL-12 production by human DCs. PGE2 per se was a weak stimulus (Fig. 1 A), but was synergized with TNF- to induce the production of high levels of IL-12 by DC (Fig. 1, C and D). This is consistent with previous reports that demonstrated that PGs are relatively weak inflammatory stimuli, but potentiate inflammatory reactions in the presence of other mediators (6, 7). Moreover, we show that PGE2 contributes to DC maturation (11) which is characterized by the downmodulation of mannose receptor–mediated endocytosis (Fig. 2 B), by the upregulation of molecules that are important for T cell activation (Fig. 3), as well as by the neo-expression of the CD83 Ag (Fig. 2 A). DC maturation can also be induced by monocyte-conditioned medium (19, 20). Our findings suggest that PGE2, which is released by activated monocytes, contributes to the DC maturation function of monocyte-conditioned medium. PGE2-treated DCs also exhibited an increased accessory cell potential which was evident as an enhanced capacity to form clusters with allogeneic T cells (data not shown) and to stimulate allogeneic T cell proliferation (Fig. 5).
Our data suggest the involvement of a cAMP signaling pathway in DC maturation since addition of db-cAMP and forskolin, which are known to increase intracellular levels of cAMP (24), mimicked the effects of PGE2. Similarly, in human monocytes, cAMP synergized with TNF- to upregulate the synthesis of IL-1β (25), suggesting that the TNF- signal transduction pathway that leads to intracellular accumulation of ceramide (26) and the PG pathway via elevation of the intracellular second messenger cAMP (24), cooperate to induce cytokine production by APCs (reference 25 and this work).
DCs obviously produce IL-12 at different anatomical sites and different states of their development. DCs residing in peripheral tissues are immature. Tissue DCs are actively endocytosing Ag. DCs cultured with GM-CSF and IL-4 exhibit high endocytic capacity and appear to correspond to these tissue DCs (11). At this state, PGE2 has stimulatory effects and strongly enhances IL-12 synthesis in the presence of TNF- (Fig. 1, C and D). The capability of immature DCs to produce large amounts of IL-12 in response to inflammatory conditions reflects the contribution of DCs to innate resistance and primarily functions to activate NK cells (27). Accumulation of inflammatory mediators then prompts DCs to migrate to the T cell areas of secondary lymphoid organs where they present Ags to recirculating T cells. During contact with Ag-specific T cells, IL-12 produced by DCs after triggering of their CD40 antigen by T cell CD40 ligand (28, 29) favors the generation of Th1 type T cell responses. At this level, PGE2 appears to inhibit T cell activation and to selectively suppress the production of Th1 cytokines (30–32). Taken together, PGE2 appears to exert both stimulatory and inhibitory effects on the development of Th1 type T cell responses depending on the site of PGE2 action.
The combination of PGE2 and TNF- induced full DC activation (Figs. 2 and 3), which included IL-12 production by DCs (Fig. 1). This mechanism of activation, which is independent of infectious Ags, may play a role in autoimmune diseases. Mononuclear cells derived from inflamed rheumatoid arthritis joints exhibited enhanced production of both PG (33) and TNF- (34), which can cooperate to increase IL-12 production (Fig. 1). IL-12 production is indeed increased in synovial mononuclear cells from arthritis patients (35) and in tubular epithelial cells of mice with lupus nephritis (36). Moreover, IL-12 is known to accelerate the development of autoimmune diseases (37). Furthermore, the induction of DC maturation by PGE2 and TNF- in the inflammatory lesions may result in continuous presentation of self Ag by fully activated DCs in vivo, and may thereby support the development of autoimmunity.
In conclusion, our data indicate that PGE2 must also be considered an important activator of human DCs. The beneficial effect of nonsteroidal antiinflammatory drugs in inflammatory diseases such as rheumatoid arthritis may relate to the inhibition of PGE2-mediated DC activation.
|
Acknowledgments
|
|---|
We gratefully acknowledge the excellent technical assistance of Christine Papesh. The authors are grateful to Dr. Nikolaus Romani for careful reading of the manuscript and to Dr. G. Utermann for kind support.
This work was supported by grant P11758MED of the Austrian Science Fund (to Martin Thurnher).
Submitted: 21 July 1997
Revised: 2 September 1997
|
References
|
|---|
1 Fearon DT & Locksley RM. The instructive role of innate immunity in the acquired immune response, Science (Wash DC), 1996, 272, 50–53.[Abstract]
2 Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, Gregory SA & Isakson PC. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo, J Exp Med, 1996, 184, 883–891.[Abstract/Free Full Text]
3 Garrison, J.C. 1990. Histamin, bradykinin, 5-hydroxytryptamine and their antagonists. In The Pharmacological Basis of Therapeutics. A. Gilman, T.W. Rall, A.S. Nies, and P. Taylor, editors. Pergamon Press, New York. 574–599.
4 Moncada S, Palmer RM & Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, 1991, 43, 109–142.[Medline]
5 Vane, J.R., and R.M. Botting. 1994. Biological properties of cyclooxygenase products. In The Handbook of Immunopharmacology. F.M. Cunningham, editor. Academic Press, London. 61–97.
6 Williams TJ & Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation, Nature (Lond), 1973, 246, 215–217.[Medline]
7 Moncada S, Ferreira SH & Vane JR. Prostaglandins, aspirin-like drugs and the oedema of inflammation, Nature (Lond), 1973, 246, 217–219.[Medline]
8 van der Pouw Kraan, T.C., L.C. Boeije, R.J. Smeenk, J. Wijdenes, and L.A. Aarden. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production, J Exp Med, 1995, 181, 775–779.[Abstract/Free Full Text]
9 Strassmann G, Patil V, Koota, Finkelman F, Fong M & Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2, J Exp Med, 1994, 180, 2365–2370.[Abstract/Free Full Text]
10 Steinman RM. The dendritic cell system and its role in immunogenicity, Annu Rev Immunol, 1991, 9, 271–296.[Medline]
11 Cella M, Sallusto F & Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells, Curr Opin Immunol, 1997, 9, 10–16.[Medline]
12 Sallusto F, Cella M, Danieli C & Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products, J Exp Med, 1995, 182, 389–400.[Abstract/Free Full Text]
13 Thurnher M, Ramoner R, Gastl G, Radmayr C, Böck G, Herold M, Klocker H & Bartsch G. Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells, Int J Cancer, 1997, 70, 128–134.[Medline]
14 Verhasselt V, Buelens C, Willems F, DeGroote D, Haeffner-Cavaillon N & Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells – evidence for a soluble CD14-dependent pathway, J Immunol, 1997, 158, 2919–2925.[Abstract]
15 Austyn JM. New insights into the mobilization and phagocytic activity of dendritic cells, J Exp Med, 1996, 183, 1287–1292.[Free Full Text]
16 Sallusto F & Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha, J Exp Med, 1994, 179, 1109–1118.[Abstract/Free Full Text]
17 Romani N, Gruner S, Brang D, Kämpgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM & Schuler G. Proliferating dendritic cell progenitors in human blood, J Exp Med, 1994, 180, 83–93.[Abstract/Free Full Text]
18 DeKruyff RH, Gieni RS & Umetsu DT. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40, J Immunol, 1997, 158, 359–366.[Abstract]
19 Romani N, Reider D, Heuer M, Ebner S, Kämpgen E, Eibl B, Niederwieser D & Schuler G. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability, J Immunol Methods, 1996, 196, 137–151.[Medline]
20 Bender A, Sapp M, Schuler G, Steinman RM & Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood, J Immunol Methods, 1996, 196, 121–135.[Medline]
21 Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I & Banchereau J. Activation of human dendritic cells through CD40 cross-linking, J Exp Med, 1994, 180, 1263–1272.[Abstract/Free Full Text]
22 Zhou LJ & Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells, Proc Natl Acad Sci USA, 1996, 93, 2588–2592.[Abstract/Free Full Text]
23 Thurnher M, Papesh C, Ramoner R, Gastl G, Böck G, Radmayr C, Klocker H & Bartsch G. In vitro generation of CD83+ human blood dendritic cells for the active tumor immunotherapy, Exp Hematol (NY), 1997, 25, 232–237.
24 Phipps RP, Stein SH & Roper RL. A new view of prostaglandin E regulation of the immune response, Immunol Today, 1991, 12, 349–352.[Medline]
25 Lorenz JJ, Furdon PJ, Taylor JD, Verghese MW, Chandra G, Kost TA, Haneline SA, Roner LA & Gray JG. A cyclic adenosine 3',5'-monophosphate signal is required for the induction of IL-1 beta by TNF- in human monocytes, J Immunol, 1995, 155, 836–844.[Abstract]
26 Sallusto F, Nicolo C, De Maria R, Corinti S & Testi R. Ceramide inhibits antigen uptake and presentation by dendritic cells, J Exp Med, 1996, 184, 2411–2416.[Abstract/Free Full Text]
27 Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity, Annu Rev Immunol, 1995, 13, 251–276.[Medline]
28 Cella M, Scheidegger D, Palmer K, Lehmann, Lane P, Lanzavecchia A & Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T–T help via APC activation, J Exp Med, 1996, 184, 747–752.[Abstract/Free Full Text]
29 Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kämpgen E, Romani N & Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10, J Exp Med, 1996, 184, 741–746.[Abstract/Free Full Text]
30 Snijdewint FG, Kalinski P, Wierenga EA, Bos JD & Kapsenberg ML. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes, J Immunol, 1993, 150, 5321–5329.[Abstract]
31 Katamura K, Shintaku N, Yamauchi Y, Fukui T, Ohshima Y, Mayumi M & Furusho K. Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-
and IL-2, but not IL-4 and IL-5, J Immunol, 1995, 155, 4604–4612.[Abstract]
32 Hilkens CM, Snijders A, Vermeulen H, van der Meide PH, Wierenga EA & Kapsenberg ML. Accessory cell–derived IL-12 and prostaglandin E2 determine the IFN- level of activated human CD4+ T cells, J Immunol, 1996, 156, 1722–1727.[Abstract]
33 Seitz M & Hunstein W. Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus, Ann Rheum Dis, 1985, 44, 438–445.[Abstract/Free Full Text]
34 Firestein GS, Alvaro JM, Gracia, Maki R, Alvaro JM & Garcia. Quantitative analysis of cytokine gene expression in rheumatoid arthritis, J Immunol, 1990, 144, 3347–3353.[Abstract]
35 Schlaak JF, Pfers I & Meyer KH. Zum Büschenfelde, and E. Marker Hermann. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies, Clin Exp Rheumatol, 1996, 14, 155–162.[Medline]
36 Fan X, Oertli B & Wuthrich RP. Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas(lpr) mice with renal injury, Kidney Int, 1997, 51, 79–86.[Medline]
37 Huang FP, Feng GJ, Lindop G, Stott DI & Liew FY. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRLMP- lpr/lprmice, J Exp Med, 1996, 183, 1447–1459.[Abstract/Free Full Text]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
-
Gruenbacher, G., Gander, H., Rahm, A., Nussbaumer, W., Romani, N., Thurnher, M.
(2009). CD56+ human blood dendritic cells effectively promote TH1-type {gamma}{delta} T-cell responses. Blood
114: 4422-4431
[Abstract]
[Full Text]
-
Jin, J.-O, Park, H.-Y., Xu, Q., Park, J.-I., Zvyagintseva, T., Stonik, V. A., Kwak, J.-Y.
(2009). Ligand of scavenger receptor class A indirectly induces maturation of human blood dendritic cells via production of tumor necrosis factor-{alpha}. Blood
113: 5839-5847
[Abstract]
[Full Text]
-
Bansal, K., Narayana, Y., Patil, S. A., Balaji, K. N.
(2009). M. bovis BCG induced expression of COX-2 involves nitric oxide-dependent and -independent signaling pathways. J. Leukoc. Biol.
85: 804-816
[Abstract]
[Full Text]
-
Hu, Y., Park-Min, K.-H., Yarilina, A., Ivashkiv, L. B.
(2008). Regulation of STAT pathways and IRF1 during human dendritic cell maturation by TNF-{alpha} and PGE2. J. Leukoc. Biol.
84: 1353-1360
[Abstract]
[Full Text]
-
Roses, R. E., Xu, S., Xu, M., Koldovsky, U., Koski, G., Czerniecki, B. J.
(2008). Differential Production of IL-23 and IL-12 by Myeloid-Derived Dendritic Cells in Response to TLR Agonists. J. Immunol.
181: 5120-5127
[Abstract]
[Full Text]
-
Khayrullina, T., Yen, J.-H., Jing, H., Ganea, D.
(2008). In Vitro Differentiation of Dendritic Cells in the Presence of Prostaglandin E2 Alters the IL-12/IL-23 Balance and Promotes Differentiation of Th17 Cells. J. Immunol.
181: 721-735
[Abstract]
[Full Text]
-
Valera, I., Fernandez, N., Trinidad, A. G., Alonso, S., Brown, G. D., Alonso, A., Crespo, M. S.
(2008). Costimulation of Dectin-1 and DC-SIGN Triggers the Arachidonic Acid Cascade in Human Monocyte-Derived Dendritic Cells. J. Immunol.
180: 5727-5736
[Abstract]
[Full Text]
-
Hamada, T., Tsuchihashi, S., Avanesyan, A., Duarte, S., Moore, C., Busuttil, R. W., Coito, A. J.
(2008). Cyclooxygenase-2 Deficiency Enhances Th2 Immune Responses and Impairs Neutrophil Recruitment in Hepatic Ischemia/Reperfusion Injury. J. Immunol.
180: 1843-1853
[Abstract]
[Full Text]
-
Krause, P., Singer, E., Darley, P. I., Klebensberger, J., Groettrup, M., Legler, D. F.
(2007). Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO. J. Leukoc. Biol.
82: 1106-1114
[Abstract]
[Full Text]
-
Bles, N., Horckmans, M., Lefort, A., Libert, F., Macours, P., El Housni, H., Marteau, F., Boeynaems, J.-M., Communi, D.
(2007). Gene Expression Profiling Defines ATP as a Key Regulator of Human Dendritic Cell Functions. J. Immunol.
179: 3550-3558
[Abstract]
[Full Text]
-
Iwamoto, S., Iwai, S.-i., Tsujiyama, K., Kurahashi, C., Takeshita, K., Naoe, M., Masunaga, A., Ogawa, Y., Oguchi, K., Miyazaki, A.
(2007). TNF-{alpha} Drives Human CD14+ Monocytes to Differentiate into CD70+ Dendritic Cells Evoking Th1 and Th17 Responses. J. Immunol.
179: 1449-1457
[Abstract]
[Full Text]
-
Longman, R. S., Braun, D., Pellegrini, S., Rice, C. M., Darnell, R. B., Albert, M. L.
(2007). Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-{alpha}/{beta} on antigen cross-presentation. Blood
109: 1113-1122
[Abstract]
[Full Text]
-
Thurnher, M.
(2007). Lipids in dendritic cell biology: messengers, effectors, and antigens. J. Leukoc. Biol.
81: 154-160
[Abstract]
[Full Text]
-
Park, K.-D., Marti, L., Kurtzberg, J., Szabolcs, P.
(2006). In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes. Blood
108: 1770-1773
[Abstract]
[Full Text]
-
Halpern, M. D., Clark, J. A., Saunders, T. A., Doelle, S. M., Hosseini, D. M., Stagner, A. M., Dvorak, B.
(2006). Reduction of experimental necrotizing enterocolitis with anti-TNF-{alpha}. Am. J. Physiol. Gastrointest. Liver Physiol.
290: G757-G764
[Abstract]
[Full Text]
-
Bagley, K. C., Abdelwahab, S. F., Tuskan, R. G., Lewis, G. K.
(2006). Cholera Toxin Indirectly Activates Human Monocyte-Derived Dendritic Cells In Vitro through the Production of Soluble Factors, Including Prostaglandin E2 and Nitric Oxide. CVI
13: 106-115
[Abstract]
[Full Text]
-
Narvaez, C. F., Angel, J., Franco, M. A.
(2005). Interaction of Rotavirus with Human Myeloid Dendritic Cells. J. Virol.
79: 14526-14535
[Abstract]
[Full Text]
-
Rubio, M. T., Means, T. K., Chakraverty, R., Shaffer, J., Fudaba, Y., Chittenden, M., Luster, A. D., Sykes, M.
(2005). Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs. Int Immunol
17: 1561-1572
[Abstract]
[Full Text]
-
Barba-Spaeth, G., Longman, R. S., Albert, M. L., Rice, C. M.
(2005). Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. JEM
202: 1179-1184
[Abstract]
[Full Text]
-
Braun, D., Longman, R. S., Albert, M. L.
(2005). A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood
106: 2375-2381
[Abstract]
[Full Text]
-
Marusic, S., Leach, M. W., Pelker, J. W., Azoitei, M. L., Uozumi, N., Cui, J., Shen, M. W.H., DeClercq, C. M., Miyashiro, J. S., Carito, B. A., Thakker, P., Simmons, D. L., Leonard, J. P., Shimizu, T., Clark, J. D.
(2005). Cytosolic phospholipase A2{alpha}-deficient mice are resistant to experimental autoimmune encephalomyelitis. JEM
202: 841-851
[Abstract]
[Full Text]
-
Vassallo, R., Tamada, K., Lau, J. S., Kroening, P. R., Chen, L.
(2005). Cigarette Smoke Extract Suppresses Human Dendritic Cell Function Leading to Preferential Induction of Th-2 Priming. J. Immunol.
175: 2684-2691
[Abstract]
[Full Text]
-
Ramoner, R., Putz, T., Gander, H., Rahm, A., Bartsch, G., Schaber, C., Thurnher, M.
(2005). Dendritic-cell activation by secretory phospholipase A2. Blood
105: 3583-3587
[Abstract]
[Full Text]
-
Schnurr, M., Toy, T., Shin, A., Wagner, M., Cebon, J., Maraskovsky, E.
(2005). Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood
105: 1582-1589
[Abstract]
[Full Text]
-
Baratelli, F. E., Heuze-Vourc'h, N., Krysan, K., Dohadwala, M., Riedl, K., Sharma, S., Dubinett, S. M.
(2004). Prostaglandin E2-Dependent Enhancement of Tissue Inhibitors of Metalloproteinases-1 Production Limits Dendritic Cell Migration through Extracellular Matrix. J. Immunol.
173: 5458-5466
[Abstract]
[Full Text]
-
Blanchard, N., Decraene, M., Yang, K., Miro-Mur, F., Amigorena, S., Hivroz, C.
(2004). Strong and Durable TCR Clustering at the T/Dendritic Cell Immune Synapse Is Not Required for NFAT Activation and IFN-{gamma} Production in Human CD4+ T Cells. J. Immunol.
173: 3062-3072
[Abstract]
[Full Text]
-
Luft, T., Maraskovsky, E., Schnurr, M., Knebel, K., Kirsch, M., Gorner, M., Skoda, R., Ho, A. D., Nawroth, P., Bierhaus, A.
(2004). Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood
104: 1066-1074
[Abstract]
[Full Text]
-
Kubo, S., Takahashi, H. K., Takei, M., Iwagaki, H., Yoshino, T., Tanaka, N., Mori, S., Nishibori, M.
(2004). E-Prostanoid (EP)2/EP4 Receptor-Dependent Maturation of Human Monocyte-Derived Dendritic Cells and Induction of Helper T2 Polarization. J. Pharmacol. Exp. Ther.
309: 1213-1220
[Abstract]
[Full Text]
-
Longman, R. S., Talal, A. H., Jacobson, I. M., Albert, M. L., Rice, C. M.
(2004). Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood
103: 1026-1029
[Abstract]
[Full Text]
-
Bagley, K. C., Abdelwahab, S. F., Tuskan, R. G., Lewis, G. K.
(2004). Calcium Signaling through Phospholipase C Activates Dendritic Cells To Mature and Is Necessary for the Activation and Maturation of Dendritic Cells Induced by Diverse Agonists. CVI
11: 77-82
[Abstract]
[Full Text]
-
Giordano, D., Magaletti, D. M., Clark, E. A., Beavo, J. A.
(2003). Cyclic Nucleotides Promote Monocyte Differentiation Toward a DC-SIGN+ (CD209) Intermediate Cell and Impair Differentiation into Dendritic Cells. J. Immunol.
171: 6421-6430
[Abstract]
[Full Text]
-
Soruri, A., Riggert, J., Schlott, T., Kiafard, Z., Dettmer, C., Zwirner, J.
(2003). Anaphylatoxin C5a Induces Monocyte Recruitment and Differentiation into Dendritic Cells by TNF-{alpha} and Prostaglandin E2-Dependent Mechanisms. J. Immunol.
171: 2631-2636
[Abstract]
[Full Text]
-
Gosset, P., Bureau, F., Angeli, V., Pichavant, M., Faveeuw, C., Tonnel, A.-B., Trottein, F.
(2003). Prostaglandin D2 Affects the Maturation of Human Monocyte-Derived Dendritic Cells: Consequence on the Polarization of Naive Th Cells. J. Immunol.
170: 4943-4952
[Abstract]
[Full Text]
-
Dauer, M., Obermaier, B., Herten, J., Haerle, C., Pohl, K., Rothenfusser, S., Schnurr, M., Endres, S., Eigler, A.
(2003). Mature Dendritic Cells Derived from Human Monocytes Within 48 Hours: A Novel Strategy for Dendritic Cell Differentiation from Blood Precursors. J. Immunol.
170: 4069-4076
[Abstract]
[Full Text]
-
Sharma, S., Stolina, M., Yang, S.-C., Baratelli, F., Lin, J. F., Atianzar, K., Luo, J., Zhu, L., Lin, Y., Huang, M., Dohadwala, M., Batra, R. K., Dubinett, S. M.
(2003). Tumor Cyclooxygenase 2-dependent Suppression of Dendritic Cell Function. Clin. Cancer Res.
9: 961-968
[Abstract]
[Full Text]
-
Ratzinger, G., Reagan, J. L., Heller, G., Busam, K. J., Young, J. W.
(2003). Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation. Blood
101: 1422-1429
[Abstract]
[Full Text]
-
Hu, H.-M., Winter, H., Ma, J., Croft, M., Urba, W. J., Fox, B. A.
(2002). CD28, TNF Receptor, and IL-12 Are Critical for CD4-Independent Cross-Priming of Therapeutic Antitumor CD8+ T Cells. J. Immunol.
169: 4897-4904
[Abstract]
[Full Text]
-
Holtl, L., Zelle-Rieser, C., Gander, H., Papesh, C., Ramoner, R., Bartsch, G., Rogatsch, H., Barsoum, A. L., Coggin, J. H. Jr., Thurnher, M.
(2002). Immunotherapy of Metastatic Renal Cell Carcinoma with Tumor Lysate-pulsed Autologous Dendritic Cells. Clin. Cancer Res.
8: 3369-3376
[Abstract]
[Full Text]
-
Scandella, E., Men, Y., Gillessen, S., Forster, R., Groettrup, M.
(2002). Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood
100: 1354-1361
[Abstract]
[Full Text]
-
Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K.-A., Maliszewski, C., Shortman, K., Cebon, J., Maraskovsky, E.
(2002). Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets. Blood
100: 1362-1372
[Abstract]
[Full Text]
-
Ni, H., Capodici, J., Cannon, G., Communi, D., Boeynaems, J.-M., Kariko, K., Weissman, D.
(2002). Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-alpha Secretion and Signaling through a Nucleotide Receptor. J. Biol. Chem.
277: 12689-12696
[Abstract]
[Full Text]
-
Luft, T., Luetjens, P., Hochrein, H., Toy, T., Masterman, K.-A., Rizkalla, M., Maliszewski, C., Shortman, K., Cebon, J., Maraskovsky, E.
(2002). IFN-{alpha} enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int Immunol
14: 367-380
[Abstract]
[Full Text]
-
Schnurr, M., Scholz, C., Rothenfusser, S., Galambos, P., Dauer, M., Robe, J., Endres, S., Eigler, A.
(2002). Apoptotic Pancreatic Tumor Cells Are Superior to Cell Lysates in Promoting Cross-Priming of Cytotoxic T Cells and Activate NK and {gamma}{delta} T Cells. Cancer Res.
62: 2347-2352
[Abstract]
[Full Text]
-
He, X., Weyand, C. M., Goronzy, J. J., Zhong, W., Stuart, J. M.
(2002). Bi-directional modulation of T cell-dependent antibody production by prostaglandin E2. Int Immunol
14: 69-77
[Abstract]
[Full Text]
-
Kambayashi, T., Wallin, R. P. A., Ljunggren, H.-G.
(2001). cAMP-elevating agents suppress dendritic cell function. J. Leukoc. Biol.
70: 903-910
[Abstract]
[Full Text]
-
Faries, M. B., Bedrosian, I., Xu, S., Koski, G., Roros, J. G., Moise, M. A., Nguyen, H. Q., Engels, F. H. C., Cohen, P. A., Czerniecki, B. J.
(2001). Calcium signaling inhibits interleukin-12 production and activates CD83+ dendritic cells that induce Th2 cell development. Blood
98: 2489-2497
[Abstract]
[Full Text]
-
Matera, L, Mori, M, Galetto, A
(2001). Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus
10: 728-734
[Abstract]
-
Schnurr, M., Galambos, P., Scholz, C., Then, F., Dauer, M., Endres, S., Eigler, A.
(2001). Tumor Cell Lysate-pulsed Human Dendritic Cells Induce a T-Cell Response against Pancreatic Carcinoma Cells: an in Vitro Model for the Assessment of Tumor Vaccines. Cancer Res.
61: 6445-6450
[Abstract]
[Full Text]
-
Morelli, A. E., Zahorchak, A. F., Larregina, A. T., Colvin, B. L., Logar, A. J., Takayama, T., Falo, L. D., Thomson, A. W.
(2001). Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood
98: 1512-1523
[Abstract]
[Full Text]
-
Wilkin, F., Duhant, X., Bruyns, C., Suarez-Huerta, N., Boeynaems, J.-M., Robaye, B.
(2001). The P2Y11 Receptor Mediates the ATP-Induced Maturation of Human Monocyte-Derived Dendritic Cells. J. Immunol.
166: 7172-7177
[Abstract]
[Full Text]
-
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., Enk, A. H.
(2001). Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood. JEM
193: 1285-1294
[Abstract]
[Full Text]
-
Kalinski, P., Vieira, P. L., Schuitemaker, J. H. N., de Jong, E. C., Kapsenberg, M. L.
(2001). Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood
97: 3466-3469
[Abstract]
[Full Text]
-
Caron, G., Delneste, Y., Roelandts, E., Duez, C., Herbault, N., Magistrelli, G., Bonnefoy, J.-Y., Pestel, J., Jeannin, P.
(2001). Histamine Induces CD86 Expression and Chemokine Production by Human Immature Dendritic Cells. J. Immunol.
166: 6000-6006
[Abstract]
[Full Text]
-
THURNHER, M., ZELLE-RIESER, C., RAMONER, R., BARTSCH, G., HOLTL, L.
(2001). The disabled dendritic cell. FASEB J.
15: 1054-1061
[Abstract]
[Full Text]
-
Ebner, S., Ratzinger, G., Krosbacher, B., Schmuth, M., Weiss, A., Reider, D., Kroczek, R. A., Herold, M., Heufler, C., Fritsch, P., Romani, N.
(2001). Production of IL-12 by Human Monocyte-Derived Dendritic Cells Is Optimal When the Stimulus Is Given at the Onset of Maturation, and Is Further Enhanced by IL-4. J. Immunol.
166: 633-641
[Abstract]
[Full Text]
-
Whittaker, D. S., Bahjat, K. S., Moldawer, L. L., Clare-Salzler, M. J.
(2000). Autoregulation of Human Monocyte-Derived Dendritic Cell Maturation and IL-12 Production by Cyclooxygenase- 2-Mediated Prostanoid Production. J. Immunol.
165: 4298-4304
[Abstract]
[Full Text]
-
Schnurr, M., Then, F., Galambos, P., Scholz, C., Siegmund, B., Endres, S., Eigler, A.
(2000). Extracellular ATP and TNF-{alpha} Synergize in the Activation and Maturation of Human Dendritic Cells. J. Immunol.
165: 4704-4709
[Abstract]
[Full Text]
-
Kaser, A., Dunzendorfer, S., Offner, F. A., Ludwiczek, O., Enrich, B., Koch, R. O., Cruikshank, W. W., Wiedermann, C. J., Tilg, H.
(2000). B Lymphocyte-Derived IL-16 Attracts Dendritic Cells and Th Cells. J. Immunol.
165: 2474-2480
[Abstract]
[Full Text]
-
Kodaira, Y., Nair, S. K., Wrenshall, L. E., Gilboa, E., Platt, J. L.
(2000). Phenotypic and Functional Maturation of Dendritic Cells Mediated by Heparan Sulfate. J. Immunol.
165: 1599-1604
[Abstract]
[Full Text]
-
Hoffmann, T. K., Meidenbauer, N., Dworacki, G., Kanaya, H., Whiteside, T. L.
(2000). Generation of Tumor-specific T Lymphocytes by Cross-Priming with Human Dendritic Cells Ingesting Apoptotic Tumor Cells. Cancer Res.
60: 3542-3549
[Abstract]
[Full Text]
-
Daro, E., Pulendran, B., Brasel, K., Teepe, M., Pettit, D., Lynch, D. H., Vremec, D., Robb, L., Shortman, K., McKenna, H. J., Maliszewski, C. R., Maraskovsky, E.
(2000). Polyethylene Glycol-Modified GM-CSF Expands CD11bhighCD11chigh But Not CD11blowCD11chigh Murine Dendritic Cells In Vivo: A Comparative Analysis with Flt3 Ligand. J. Immunol.
165: 49-58
[Abstract]
[Full Text]
-
Klein, T. W., Newton, C. A., Nakachi, N., Friedman, H.
(2000). {Delta}9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-{gamma}, IL-12, and IL-12 Receptor {beta}2 Responses to Legionella pneumophila Infection. J. Immunol.
164: 6461-6466
[Abstract]
[Full Text]
-
Klein, C., Bueler, H., Mulligan, R. C.
(2000). Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines. JEM
191: 1699-1708
[Abstract]
[Full Text]
-
Prehn, J. L., Landers, C. J., Targan, S. R.
(1999). A Soluble Factor Produced by Lamina Propria Mononuclear Cells Is Required for TNF-{alpha} Enhancement of IFN-{gamma} Production by T Cells. J. Immunol.
163: 4277-4283
[Abstract]
[Full Text]
-
Delneste, Y., Herbault, N., Galea, B., Magistrelli, G., Bazin, I., Bonnefoy, J.-Y., Jeannin, P.
(1999). Vasoactive Intestinal Peptide Synergizes with TNF-{alpha} in Inducing Human Dendritic Cell Maturation. J. Immunol.
163: 3071-3075
[Abstract]
[Full Text]
-
Kaser, A., Dunzendorfer, S., Offner, F. A., Ryan, T., Schwabegger, A., Cruikshank, W. W., Wiedermann, C. J., Tilg, H.
(1999). A Role for IL-16 in the Cross-Talk Between Dendritic Cells and T Cells. J. Immunol.
163: 3232-3238
[Abstract]
[Full Text]
-
Wani, M. R., Fuller, K., Kim, N. S., Choi, Y., Chambers, T.
(1999). Prostaglandin E2 Cooperates with TRANCE in Osteoclast Induction from Hemopoietic Precursors: Synergistic Activation of Differentiation, Cell Spreading, and Fusion. Endocrinology
140: 1927-1935
[Abstract]
[Full Text]
-
Waldrop, S. L., Davis, K. A., Maino, V. C., Picker, L. J.
(1998). Normal Human CD4+ Memory T Cells Display Broad Heterogeneity in Their Activation Threshold for Cytokine Synthesis. J. Immunol.
161: 5284-5295
[Abstract]
[Full Text]
-
Albert, M. L., Pearce, S.F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., Bhardwaj, N.
(1998). Immature Dendritic Cells Phagocytose Apoptotic Cells via {alpha}v{beta}5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes. JEM
188: 1359-1368
[Abstract]
[Full Text]
-
Wu, C.-Y., Wang, K., McDyer, J. F., Seder, R. A.
(1998). Prostaglandin E2 and Dexamethasone Inhibit IL-12 Receptor Expression and IL-12 Responsiveness. J. Immunol.
161: 2723-2730
[Abstract]
[Full Text]
-
Kalinski, P., Schuitemaker, J. H. N., Hilkens, C. M. U., Kapsenberg, M. L.
(1998). Prostaglandin E2 Induces the Final Maturation of IL-12-Deficient CD1a+CD83+ Dendritic Cells: The Levels of IL-12 Are Determined During the Final Dendritic Cell Maturation and Are Resistant to Further Modulation. J. Immunol.
161: 2804-2809
[Abstract]
[Full Text]
-
Randolph, G. J., Beaulieu, S., Pope, M., Sugawara, I., Hoffman, L., Steinman, R. M., Muller, W. A.
(1998). A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. USA
95: 6924-6929
[Abstract]
[Full Text]
-
Rieser, C., Papesh, C., Herold, M., Bock, G., Ramoner, R., Klocker, H., Bartsch, G., Thurnher, M.
(1998). Differential Deactivation of Human Dendritic Cells by Endotoxin Desensitization: Role of Tumor Necrosis Factor-alpha and Prostaglandin E2. Blood
91: 3112-3117
[Abstract]
[Full Text]
Top
Abstract
Materials and Methods
